Role of neurotrophic factors in depression

Current Opinion in Pharmacology

Volumn 7, Issue 1, 2007, Pages 18-21

  Castrén, Eero ^a   Võikar, Vootele ^a   Rantamäki, Tomi ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE; FIBROBLAST GROWTH FACTOR; LITHIUM; MESSENGER RNA; NEUROTROPHIC FACTOR; SOMATOMEDIN C; VASCULOTROPIN;

BRAIN NERVE CELL; BRAIN SIZE; CELL MATURATION; ELECTROCONVULSIVE THERAPY; HIPPOCAMPUS; HUMAN; MAJOR DEPRESSION; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; SYNAPTOGENESIS;

ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSION; HUMANS; MOOD DISORDERS; NERVE GROWTH FACTORS; STRESS;

EID: 33846903377     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2006.08.009     Document Type: Review

References (32)

1. Huang E.J., and Reichardt L.F. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 24 (2001) 677-736
2. Castrén E. Neurotrophic effects of antidepressant drugs. Curr Opin Pharmacol 4 (2004) 58-64
3. Castrén E. Is mood chemistry?. Nat Rev Neurosci 6 (2005) 241-246
4. Duman R.S., and Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59 (2006) 1116-1127
5. Chen B., Dowlatshahi D., MacQueen G.M., Wang J.F., and Young L.T. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 50 (2001) 260-265
6. Karege F., Bondolfi G., Gervasoni N., Schwald M., Aubry J.M., and Bertschy G. Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatry 57 (2005) 1068-1072
7. Shimizu E., Hashimoto K., Okamura N., Koike K., Komatsu N., Kumakiri C., Nakazato M., Watanabe H., Shinoda N., Okada S., and Iyo M. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 54 (2003) 70-75
8. Fuchs E., Czeh B., Kole M.H.P., Michaelis T., and Lucassen P.J. Alterations of neuroplasticity in depression: the hippocampus and beyond. Eur Neuropsychopharmacol 14 (2004) S481-S490
9. Tsankova N.M., Berton O., Renthal W., Kumar A., Neve R.L., and Nestler E.J. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 9 (2006) 519-525. This study shows that social defeat stress produces a sustained suppression of BDNF transcription through histone methylation, whereas antidepressants restore BDNF synthesis through histone acetylation. Antidepressants reduce histone deacetylase-5, and overexpression of this enzyme in the hippocampus prevents the effects of antidepressants on BDNF mRNA.
10. Warner-Schmidt J.L., and Duman R.S. Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment. Hippocampus 16 (2006) 239-249
11. Rantamaki T., Knuuttila J.E., Hokkanen M.E., and Castren E. The effects of acute and long-term lithium treatments on trkB neurotrophin receptor activation in the mouse hippocampus and anterior cingulate cortex. Neuropharmacology 50 (2006) 421-427
12. Saarelainen T., Hendolin P., Lucas G., Koponen E., Sairanen M., MacDonald E., Agerman K., Haapasalo A., Nawa H., Aloyz R., et al. Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J Neurosci 23 (2003) 349-357
13. Monteggia L.M., Barrot M., Powell C.M., Berton O., Galanis V., Gemelli T., Meuth S., Nagy A., Greene R.W., and Nestler E.J. Essential role of brain-derived neurotrophic factor in adult hippocampal function. Proc Natl Acad Sci USA 101 (2004) 10827-10832
14. Monteggia LM, Luikart B, Barrot M, Theobold D, Malkovska I, Nef S, Parada LF, Nestler EJ: Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors. Biol Psychiatry 2006, in press.
15. Koponen E., Rantamaki T., Voikar V., Saarelainen T., MacDonald E., and Castren E. Enhanced BDNF signaling is associated with an antidepressant-like behavioral response and changes in brain monoamines. Cell Mol Neurobiol 25 (2005) 973-980
16. Sairanen M., Lucas G., Ernfors P., Castren M., and Castren E. Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. J Neurosci 25 (2005) 1089-1094. This paper shows that inhibition of BDNF signaling does not influence antidepressant-induced neurogenesis, but that BDNF is required for the long-term survival of the newborn dentate granule neurons.
17. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., Weisstaub N., Lee J., Duman R., Arancio O., et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301 (2003) 805-809
18. Vaidya V.A., Siuciak J.A., Du F., and Duman R.S. Hippocampal mossy fiber sprouting induced by chronic electroconvulsive seizures. Neuroscience 89 (1999) 157-166
19. Fujioka T., Fujioka A., and Duman R.S. Activation of cAMP signaling facilitates the morphological maturation of newborn neurons in adult hippocampus. J Neurosci 24 (2004) 319-328
20. Hajszan T., MacLusky N.J., and Leranth C. Short-term treatment with the antidepressant fluoxetine triggers pyramidal dendritic spine synapse formation in rat hippocampus. Eur J Neurosci 21 (2005) 1299-1303. This paper shows that antidepressants increase synaptogenesis in the hippocampus, both in the CA1 region where neurogenesis does not occur, and subsequently in the CA3 region, which is the target of newborn dentate granule neurons.
21. Sairanen M, O'Leary OF, Knuuttila JE, Castrén E: Chronic antidepressant treatment selectively increases expression of plasticity-related proteins in the hippocampus and medial prefrontal cortex of the rat. Neuroscience 2006, in press.
22. Koponen E., Võikar V., Riekki R., Saarelainen T., Rauramaa T., Rauvala H., Taira T., and Castrén E. Transgenic mice overexpressing the full-length neurotrophin receptor trkB exhibit increased activation of trkB/PLCγ pathway, reduced anxiety, and facilitated learning. Mol Cell Neurosci 26 (2004) 166-181
23. Eisch A.J., Bolanos C.A., De Wit J., Simonak R.D., Pudiak C.M., Barrot M., Verhaagen J., and Nestler E.J. Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: a role in depression. Biol Psychiatry 54 (2003) 994-1005
24. Berton O., McClung C.A., DiLeone R.J., Krishnan V., Renthal W., Russo S.J., Graham D., Tsankova N.M., Bolanos C.A., Rios M., et al. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311 (2006) 864-868. Deletion of BDNF from the mesolimbic dopamine pathway blocks the depression-like behavior produced by repeated social defeat. BDNF deletion mimics both the behavioral and gene expression effects of antidepressant drugs.
25. Nestler E.J., and Carlezon Jr. W.A. The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 59 (2006) 1151-1159
26. Evans S.J., Choudary P.V., Neal C.R., Li J.Z., Vawter M.P., Tomita H., Lopez J.F., Thompson R.C., Meng F., Stead J.D., et al. Dysregulation of the fibroblast growth factor system in major depression. Proc Natl Acad Sci USA 101 (2004) 15506-15511
27. Riva M.A., Molteni R., Bedogni F., Racagni G., and Fumagalli F. Emerging role of the FGF system in psychiatric disorders. Trends Pharmacol Sci 26 (2005) 228-231
28. Khawaja X., Xu J., Liang J.J., and Barrett J.E. Proteomic analysis of protein changes developing in rat hippocampus after chronic antidepressant treatment: Implications for depressive disorders and future therapies. J Neurosci Res 75 (2004) 451-460
29. Hoshaw B.A., Malberg J.E., and Lucki I. Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects. Brain Res 1037 (2005) 204-208. Brain injection of either IGF-1 or BDNF mimics the behavioral response of antidepressants in the forced swim test, and the effects are long-lasting.
30. Kodama M., Fujioka T., and Duman R.S. Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat. Biol Psychiatry 56 (2004) 570-580
31. Madsen T.M., Yeh D.D., Valentine G.W., and Duman R.S. Electroconvulsive seizure treatment increases cell proliferation in rat frontal cortex. Neuropsychopharmacology 30 (2005) 27-34
32. Newton S.S., Collier E.F., Hunsberger J., Adams D., Terwilliger R., Selvanayagam E., and Duman R.S. Gene profile of electroconvulsive seizures: induction of neurotrophic and angiogenic factors. J Neurosci 23 (2003) 10841-10851